Elisa Tremante
Rome, 00144, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The Role of LncRNAs in Radio- and Chemoresistance of Glioblastoma: Prognostic or Therapeutic?
Journal: Current oncology (Toronto, Ont.)
Published: August 07, 2025
Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1/miR-26a-1/miR-487b signature mediated WT1 and FOXA1 silencing.
Journal: Cell death discovery
Published: March 18, 2025
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers.
Journal: Heliyon
Published: September 22, 2023
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 14, 2023
[Corrigendum] TOOLBOX: Strep‑Tagged nano‑assemblies of antibody‑drug‑conjugates (ADC) for modular and conditional cancer drugging.
Journal: Oncology reports
Published: November 26, 2020
Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers.
Journal: Neuropathology and applied neurobiology
Published: September 15, 2020
The presence of glutamate residues on the PAS sequence of the stimuli-sensitive nano-ferritin improves in vivo biodistribution and mitoxantrone encapsulation homogeneity.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 15, 2017
Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA).
Journal: Journal of experimental & clinical cancer research : CR
Published: November 08, 2017
Detection of soluble ERBB2 in breast cancer cell lysates using a combined label-free/fluorescence platform based on Bloch surface waves.
Journal: Biosensors & bioelectronics
Published: November 03, 2016
Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 10, 2016
Last Updated: 09/26/2026